Nils A t Hart
Overview
Explore the profile of Nils A t Hart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hempenius M, Eenkhoorn M, Hoeg H, Dabbs D, van der Vegt B, Sompuram S, et al.
Histopathology
. 2024 Jul;
85(6):920-928.
PMID: 39075657
Aims: Recently, human epidermal growth factor 2 (HER2)-low (i.e. HER2 score 1+ or 2+ without amplification) breast cancer patients became eligible for trastuzumab-deruxtecan treatment. To improve assay standardisation and detection...
2.
Dabbs D, Chiriboga L, Jasani B, Kinloch M, Miller K, Nielsen S, et al.
Arch Pathol Lab Med
. 2023 Dec;
148(1):11.
PMID: 38157868
No abstract available.
3.
Sompuram S, Torlakovic E, t Hart N, Vani K, Bogen S
Mod Pathol
. 2023 Feb;
36(2):100057.
PMID: 36853795
No abstract available.
4.
Steenhuis E, Brus M, t Hart N, Kodach L, Nijboer-Oosterveld J, Tomlow B
Chest
. 2022 Apr;
161(4):e233-e240.
PMID: 35396057
A 20-year-old woman presented with dry cough, right-sided thoracic pain, and gradually progressive dyspnea on exertion. She had no hemoptysis or fever. There was no relevant medical history. She was...
5.
Butter R, Hondelink L, van Elswijk L, Blaauwgeers J, Bloemena E, Britstra R, et al.
Lung Cancer
. 2022 Mar;
166:143-149.
PMID: 35279453
Objectives: Programmed death-ligand 1 (PD-L1) is the only approved predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC). However, predictive PD-L1 immunohistochemistry is subject to interobserver variability. We hypothesized...
6.
Sompuram S, Torlakovic E, t Hart N, Vani K, Bogen S
Mod Pathol
. 2021 Sep;
34(12):2242.
PMID: 34493826
No abstract available.
7.
Sompuram S, Torlakovic E, t Hart N, Vani K, Bogen S
Mod Pathol
. 2021 Aug;
35(3):326-332.
PMID: 34389791
Companion diagnostic immunohistochemistry (IHC) tests are developed and performed without incorporating the tools and principles of laboratory metrology. Basic analytic assay parameters such as lower limit of detection (LOD) and...
8.
van Zanden J, t Hart N, Ottens P, Liu B, Rebolledo R, Erasmus M, et al.
Front Pharmacol
. 2021 Mar;
12:587003.
PMID: 33692687
The process of brain death (BD) leads to a pro-inflammatory state of the donor lung, which deteriorates its quality. In an attempt to preserve lung quality, methylprednisolone is widely recommended...
9.
Haanschoten D, Adiyaman A, t Hart N, Jager P, Elvan A
Eur J Clin Invest
. 2021 Jan;
51(4):e13497.
PMID: 33482016
Aim: Integration of endomyocardial biopsy (EMB) in the diagnostic workup of cardiac sarcoidosis (CS) is under-recognized in current clinical practice, since capturing focal granulomas is challenging. Our aim was to...
10.
Koomen B, Starre-Gaal J, Vonk J, von der Thusen J, van der Meij J, Monkhorst K, et al.
Cancer Cytopathol
. 2020 Oct;
129(4):304-317.
PMID: 33108706
Background: Immunohistochemical staining of programmed death-ligand 1 (PD-L1) is used to determine which patients with non-small cell lung cancer (NSCLC) may benefit most from immunotherapy. Therapeutic management of many patients...